Brief: Aurobindo Pharma Q1 Consol Net PAT 10.33 Billion Rupees
05/08/2026 15:28
BRIEF-Aurobindo Pharma Q1 Consol Net PAT 10.33 Billion Rupees Aug 5 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA Q1 CONSOL NET PAT 10.33 BILLION RUPEES
AUROBINDO PHARMA Q1 CONSOL TOTAL REVENUE FROM OPERATIONS 91.5 BILLION RUPEES
AUROBINDO PHARMA - TO FILE SCHEME OF AMALGAMATION OF EUGIA STERILES AND EUGIA SEZ WITH EUGIA PHARMA SPECIALITIES
Source text: [ID:]
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11